Reportlinker Adds The Blood Banking Market: US, Europe, Japan - Emerging Opportunities and Business Development Strategies

Jun 21, 2010, 14:16 ET from Reportlinker

NEW YORK, June 21 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Blood Banking Market: US, Europe, Japan - Emerging Opportunities and Business Development Strategies

http://www.reportlinker.com/p0207091/The-Blood-Banking-Market-US-Europe-Japan---Emerging-Opportunities-and-Business-Development-Strategies.html

During the next ten years, the blood banking market will undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation is more critical than underlying technology. The changes in the marketplace, however, will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.

This comprehensive worldwide study is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next ten years, and to assist industry executives in developing effective business, new product development and marketing strategies. The study explores future marketing and technological trends in the US, Europe and Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years.

Contains 850 pages and 240 tables

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch. 

I. INTRODUCTION

II. WORLDWIDE TECHNOLOGY AND MARKET OVERVIEW

A. MAJOR BLOOD TYPING, GROUPING & INFECTIOUS DISEASE SCREENING TESTS

1. Blood Typing and Grouping Tests

a. ABO

b. Antibody Panels

c. Antibody Screening

d. Antigen Typing

e. Antiglobulin Test

f. Crossmatch

g. HLA Typing

h. Rh

i. Other Blood Groups

2. Infectious Disease Screening Tests

a. AIDS

Structure & Composition

Classification

HIV-2 Infection

Origin of AIDS

Animal Lentivirus Systems

Virus Receptors

HIV Infections in Humans

Pathogenesis & Pathology

Overview of Infection Course

CD4T Lymphocytes and Memory Cells

Monocytes & Macrophages

Lymphoid Organs

Neural Cells

Viral Coinfections

Clinical Findings

Plasma Viral Load

Pediatric AIDS

Neurologic Disease

Opportunistic Infections

Protozoa

Fungi

Bacteria

Viruses

Cancer

Immunity

Laboratory Diagnosis

Virus Isolation

Serology

Detection of Viral Nucleic Acid or Antigens

Epidemiology

Worldwide Spread

United States

Transmission Routes

Prevention, Treatment & Control

Antiviral Drugs

Vaccines

Transmission in Blood Products

Transmission in Transplant & Artificial Insemination Recipients

Diagnostic Tests

EIA Interpretation

Specificity, Sensitivity & Predictive Value

Competition Assays

Western Blot

IFA

Radioimmunoprecipitation

HIV-1 HIV-2 Combination Testing

Methods of HIV Antigen Detection

Antigen Assays & Blood Screening

Urine Tests

DNA Probes

Overview

Quantitative PCR

In Situ PCR

Needed Improvements

Viral Load/Drug Resistance Testing

Genotype & Phenotype Testing

Blood Banking Considerations

b. Hepatitis

Hepatitis A

Hepatitis B

Structure & Composition

Replication

Hepatitis C

Hepatitis D (Delta)

Hepatitis E

Hepatitis G

Infections in Humans

Pathology

Clinical Findings

Laboratory Features

Hepatitis A

Hepatitis B

Hepatitis C

Hepatitis D

Hepatitis E

Virus-Host Immune Reactions

Epidemiology

Hepatitis A

Hepatitis B

Hepatitis C

Hepatitis D (Delta)

Vaccines and Drugs

c. Cytomegalovirus

Background

Chorioretinitis

Gastrointestinal

Central Nervous System

Diagnostic Tests

Vaccines and Drugs

d. Syphilis

Background

Diagnostic Tests

Vaccines and Drugs

e. West Nile Virus

Background

Clinical Syndromes

Diagnostic Tests

Vaccines and Drugs

f. Parvovirus B19

Microbiology

Epidemiology

Clinical Syndromes

Erythema Infectiosum

Adult Polyarthropathy

Transient Aplastic Crisis

Transient Pancytopenia

Red Cell Aplasia in Immunocompromised

Perinatal Infections

Diagnosis

Treatment

g. Creutzfeldt-Jakob's Disease

Background

Transmission

Diagnostic Tests

Major Players

Bayer

Disease Sciences/BioTec Global

Imperial College School of Medicine

Ortho-Clinical Diagnostics

Pall

ProMetic Life Sciences

Proteome Sciences/Idexx

Q-One Biotech

Serono

U.S. Agricultural Research

Drugs

Vaccines

h. Malaria

i. Chagas Disease

j. Babesiosis

3. Pathogen Reduction

4. Leukocyte Reduction

a. Background

b. Methods

B. INSTRUMENTATION REVIEW

1. Abbott Prism

2. Abbott Quantum II

3. Abbott Commander

4. BioMeriuex BacT/Alert

5. Dade Behring Quadriga

6. Dade Behring BEP 2000

7. Grifols Diana

8. Immucor ABS2000

9. Immucor Galileo

10. Immucor Rosys Plato

11. Olympus PK7100

12. Olympus PK7200

13. Olympus PK80

14. Olympus BloodTrack Courier

15. Ortho AutoVue

16. Ortho ProVue

17. Ortho Summit Processor

18. Tecan ELPHAtyper

19. Tecan Hemotyper

20. Tecan MegaFlex

21. Tecan MiniSwift

C. MAJOR IN VITRO DIAGNOSTIC TECHNOLOGIES AND APPLICATIONS

1. Molecular Diagnostics

a. Overview

b. NAT

2. Monoclonal and Polyclonal Antibodies

3. Immunoassays

a. Technological Principle

b. Enzyme Immunoassays

Overview

ELISA

Enzyme Amplification

c. Fluorescent Immunoassays

Fluorescence Polarization

d. Luminescence

Chemiluminescence

Bioluminescence

e. Latex Agglutination

f. Immunoprecipitation

4. Microtitration Plates

5. Microcomputers

6. Automation

7. Lasers

8. Robotics

9. Artificial Intelligence

10. Synthetic Red Cell Substitutes

11. Genetically Engineered Blood Components

a. Albumin

b. Factor VIII

c. Alpha-2 Antiplasmin

d. Antithrombin III

e. Factor IX

f. Von Willebrand's Factor

g. Fibrinogen

h. t-PA

12. Blood Preservation

13. Autologous Blood Transfusion/Freezing

D. WORLDWIDE MARKET OVERVIEW

1. Business Environment

2. Market Structure

3. Market Size and Growth

III. FRANCE

A. EXECUTIVE SUMMARY

B. BUSINESS ENVIRONMENT

C. MARKET STRUCTURE

D. MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' CONSUMABLE SALES, INSTRUMENT PLACEMENTS, INSTALLED BASE AND MARKET SHARES

IV. GERMANY

A. EXECUTIVE SUMMARY

B. BUSINESS ENVIRONMENT

C. MARKET STRUCTURE

D. MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' CONSUMABLE SALES, INSTRUMENT PLACEMENTS, INSTALLED BASE AND MARKET SHARES

V. ITALY

A. EXECUTIVE SUMMARY

B. BUSINESS ENVIRONMENT

C. MARKET STRUCTURE

D. MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' CONSUMABLE SALES, INSTRUMENT PLACEMENTS, INSTALLED BASE AND MARKET SHARES

VI. JAPAN

A. EXECUTIVE SUMMARY

B. BUSINESS ENVIRONMENT

C. MARKET STRUCTURE

D. MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' CONSUMABLE SALES, INSTRUMENT PLACEMENTS, INSTALLED BASE AND MARKET SHARES

VII. SPAIN

A. EXECUTIVE SUMMARY

B. BUSINESS ENVIRONMENT

C. MARKET STRUCTURE

D. MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' CONSUMABLE SALES, INSTRUMENT PLACEMENTS, INSTALLED BASE AND MARKET SHARES

VIII. U.K.

A. EXECUTIVE SUMMARY

B. BUSINESS ENVIRONMENT

C. MARKET STRUCTURE

D. MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' CONSUMABLE SALES, INSTRUMENT PLACEMENTS, INSTALLED BASE AND MARKET SHARES

IX. U.S.A.

A. EXECUTIVE SUMMARY

B. BUSINESS ENVIRONMENT

1. Overview

2. Health Care Expenditures

3 Cost Consciousness

4. Reimbursement

5. Industry Consolidation

6. Managed Care

a. HMO

b. PPO

7. Hospitals

8. Admissions

9. Length of Stay

10. Industry Diversification

11. Physician Demographics

12. Population Aging

a. Chronic Illnesses

b. Disease Incidence

c. Susceptibility to Iatrogenesis

d. Multiple Illness Cases

13. Laboratory Regulations

14. FDA Reform

C. MARKET STRUCTURE

1. Testing Facilities

a. Community and Regional Centers

b. Plasma Fractionation Centers

c. Hospitals

d. Commercial/Private Labs

e. Military Blood Banks

f. Commercial Blood Banks

2. Collection Facilities

D. MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' CONSUMABLE SALES, INSTRUMENT PLACEMENTS, INSTALLED BASE AND MARKET SHARES

X. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. BLOOD TYPING AND GROUPING

B. INFECTIOUS DISEASE SCREENING

C. AUXILIARY

XI. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. INTERNAL DEVELOPMENT

B. COLLABORATIVE ARRANGEMENTS

C. UNIVERSITY CONTRACTS

XII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. MARKET MATURITY

B. COST CONTAINMENT

C. COMPETITION

D. TECHNOLOGICAL EDGE AND LIMITATIONS

E. PATENT PROTECTION

F. REGULATORY CONSTRAINTS

XIII. COMPETITIVE ASSESSMENTS

Abbott

Beckman Coulter

Biokit

BioMerieux

Bio-Rad

Bioscot

Biotest

Chiron

Diagast

Diamed

DiaSorin

Fujirebio

Gen-Probe

Gradipore

Grifols

ImmucorGamma

Innogenetics

Orchid Biosciences

Ortho-Clinical Diagnostics

Proteome Sciences

Roche

Siemens

Tecan

XIV. APPENDIX: ASSUMED CURRENCY EXCHANGE RATES

To order this report:

Blood Supply, Tissue Banking and Transplantation Industry: The Blood Banking Market: US, Europe, Japan - Emerging Opportunities and Business Development Strategies

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626



SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com